1-palmitoyl-2-(6-(n-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine has been researched along with Respiratory Distress Syndrome, Newborn in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, TJ; Chen, C; Roby, PV; Tait, JF; Weiss, NS; Wilson, JA | 1 |
1 other study(ies) available for 1-palmitoyl-2-(6-(n-(7-nitrobenz)-2-oxa-1,3-diazol-4-yl)aminocaproyl)phosphatidylcholine and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Clinical evaluation of the NBD-PC fluorescence polarization assay for prediction of fetal lung maturity.
Topics: Amniotic Fluid; Evaluation Studies as Topic; Female; Fetal Organ Maturity; Fluorescence Polarization; Gestational Age; Humans; Infant, Newborn; Lung; Phosphatidylcholines; Phospholipids; Predictive Value of Tests; Pregnancy; Pregnancy in Diabetics; Pulmonary Surfactants; Reference Values; Respiratory Distress Syndrome, Newborn; Sensitivity and Specificity; Sphingomyelins | 1992 |